TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive FDA Announces Plan to Reform Drug Approval, Hire Outside Experts To Handel Some Reviews November 22, 1991